Knockout Drug Screens: Cell lines that differ by a single genetic change show promise in drug screens to identify compounds with gene-selective properties

Nature Biotechnology

Volumn 19, Issue 10, 2001, Pages 919-920

  Prendergast, George C ^a  

^a DuPont Pharmaceuticals Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CELL CULTURE; CELL DIVISION; CELL LINE; DRUG EFFECT; DRUG SCREENING; FLUORESCENCE; METHODOLOGY; NOTE; ONCOGENE RAS;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE; GENES, RAS; TUMOR CELLS, CULTURED;

EID: 0035491318     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1001-919     Document Type: Article

References (7)

1. Torrance, C.J. et al. Nat. Biotechnol. 19, 940–945 (2001).
2. Huang, P.S. & Oliff A. Curr. Opin. Genet. Dev. 11, 104–110 (2001).
3. Gibbs, J.B. Science 287, 1969–1973 (2000).
4. Carpenter, C.L. & Cantley, L.C. Curr. Opin. Cell Biol. 8, 153–158 (1996).
5. Campbell, V.W. et al. Am. J. Med. Sci. 307, 167–172 (1994).
6. Koo, H.M., et al. Cancer Res. 59, 6057–6062 (2000).
7. Shirasawa, S. et al. Science 260, 85–88 (1993).